262 related articles for article (PubMed ID: 23046024)
21. Metastatic melanoma: the new era of targeted therapy.
Guida M; Pisconti S; Colucci G
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S61-70. PubMed ID: 22443134
[TBL] [Abstract][Full Text] [Related]
22. Targeting metastatic melanoma.
Flaherty KT
Annu Rev Med; 2012; 63():171-83. PubMed ID: 22034865
[TBL] [Abstract][Full Text] [Related]
23. Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?
Dummer R; Schadendorf D; Ascierto PA; Larkin J; Lebbé C; Hauschild A
Melanoma Res; 2015 Dec; 25(6):461-9. PubMed ID: 26426764
[TBL] [Abstract][Full Text] [Related]
24. BRAF, a target in melanoma: implications for solid tumor drug development.
Flaherty KT; McArthur G
Cancer; 2010 Nov; 116(21):4902-13. PubMed ID: 20629085
[TBL] [Abstract][Full Text] [Related]
25. Therapy for metastatic melanoma: the past, present, and future.
Finn L; Markovic SN; Joseph RW
BMC Med; 2012 Mar; 10():23. PubMed ID: 22385436
[TBL] [Abstract][Full Text] [Related]
26. [Molecular-target therapy for advanced malignant melanoma].
Takahashi S
Gan To Kagaku Ryoho; 2013 Jan; 40(1):19-25. PubMed ID: 23306915
[TBL] [Abstract][Full Text] [Related]
27. Therapy for metastatic melanoma: an overview and update.
Boyle GM
Expert Rev Anticancer Ther; 2011 May; 11(5):725-37. PubMed ID: 21554048
[TBL] [Abstract][Full Text] [Related]
28. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
29. New therapeutic agents in uveal melanoma.
Velho TR; Kapiteijn E; Jager MJ
Anticancer Res; 2012 Jul; 32(7):2591-8. PubMed ID: 22753717
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticle-mediated drug delivery for treating melanoma.
Mundra V; Li W; Mahato RI
Nanomedicine (Lond); 2015; 10(16):2613-33. PubMed ID: 26244818
[TBL] [Abstract][Full Text] [Related]
31. Treatment for metastatic malignant melanoma: old drugs and new strategies.
Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
[TBL] [Abstract][Full Text] [Related]
32. Advances in systemic treatment of melanoma.
Eggermont AM
Ann Oncol; 2010 Oct; 21 Suppl 7():vii339-44. PubMed ID: 20943639
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous melanoma: available therapy for metastatic disease.
Tarhini AA; Agarwala SS
Dermatol Ther; 2006; 19(1):19-25. PubMed ID: 16405566
[TBL] [Abstract][Full Text] [Related]
34. Management of metastatic melanoma.
Tawbi HA; Kirkwood JM
Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
[TBL] [Abstract][Full Text] [Related]
35. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
36. The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
Murrell J; Board R
Cancer Treat Rev; 2013 Dec; 39(8):833-8. PubMed ID: 23845462
[TBL] [Abstract][Full Text] [Related]
37. Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States.
Ma Q; Chen YJ; Hines DM; Munakata J; Batty N; Barber BL; Zhao Z
J Dermatolog Treat; 2017 Sep; 28(6):549-553. PubMed ID: 28100090
[TBL] [Abstract][Full Text] [Related]
38. Novel inhibitors in the treatment of metastatic melanoma.
Kalinsky K; Haluska FG
Expert Rev Anticancer Ther; 2007 May; 7(5):715-24. PubMed ID: 17492934
[TBL] [Abstract][Full Text] [Related]
39. [Adjuvant systemic treatment of melanoma].
Kähler KC; Egberts F; Hauschild A; Mohr P
Hautarzt; 2011 Jun; 62(6):414, 416-22. PubMed ID: 21656113
[TBL] [Abstract][Full Text] [Related]
40. [Melanoma and search for therapeutic targets].
de la Fouchardière A
Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]